Recent Quotes (30 days)

You have no recent quotes
chg | %

Vanco plc news

  
Showing stories 1 - 5 of about 5   

Articles published

ANI Pharmaceuticals Acquires Vancocin´┐Ż Capsules and Additional Vancomycin ...
1, 2014 /PRNewswire/ -- ANI Pharmaceuticals, Inc. ANIP, -0.07% today announced that it has acquired the US rights for Vancocin´┐Ż 125 mg and 250 mg capsules from Shire plc, a global biopharmaceutical company. In addition, ANI acquired from Shire ...
ANI Pharma Acquires Vancocin Capsules, Additional Vancomycin Assets From ...  NASDAQ
Related articles »  
Theravance Biopharma, Inc. Reports Second Quarter 2014 Financial Results
On June 2, 2014, Theravance, Inc. ("Theravance") completed the separation of its late-stage respiratory assets partnered with GlaxoSmithKline plc ("GSK") from its discovery, development and commercialization operations via a pro rata dividend ...
Related articles »  
Drug Stocks Edged Up: GlaxoSmithKline plc (NYSE:GSK), AstraZeneca PLC ...
AstraZeneca PLC (NYSE:AZN) return on investment (ROI) is 9.00% while return on equity (ROE) is 9.00%. ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) acquires Vancocin capsules and additional vancomycin assets from Shire. Return on Investment for ANI ...
Related articles »  
ANI Pharma buys US rights for Vancocin capsules from Shire
In addition, we will immediately begin exploring opportunities to launch both vancomycin injectable and vancomycin oral solution.
Related articles »  
Vanco plc Announces Placing of New Ordinary Shares